Abstract
The aim of this paper was to critically review the current treatment of anxiety disorders including general anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. For all these disorders, this paper will suggest treatment guidelines based on literature data as well as personal experience. Obsessive compulsive disorder (OCD) even considered in DSM IV as an anxiety disorder is somewhere different from the other anxiety disorder (almost lack of placebo response, efficacy of cognitive- behavioural therapy and deep brain stimulation).
Keywords: Benzodiazepines, serotonin selective reuptake inhibitors (SSRIs), antidepressants, generalized anxiety disorder (GAD), panic disorder (PD), social anxiety disorder (SAD), post traumatic stress disorder (PTSD).
Current Psychopharmacology
Title:A Critical Approach of the Current Treatment of Anxiety Disorders
Volume: 2
Author(s): Michel Bourin and Florence Thibaut
Affiliation:
Keywords: Benzodiazepines, serotonin selective reuptake inhibitors (SSRIs), antidepressants, generalized anxiety disorder (GAD), panic disorder (PD), social anxiety disorder (SAD), post traumatic stress disorder (PTSD).
Abstract: The aim of this paper was to critically review the current treatment of anxiety disorders including general anxiety disorder, panic disorder, social anxiety disorder and post-traumatic stress disorder. For all these disorders, this paper will suggest treatment guidelines based on literature data as well as personal experience. Obsessive compulsive disorder (OCD) even considered in DSM IV as an anxiety disorder is somewhere different from the other anxiety disorder (almost lack of placebo response, efficacy of cognitive- behavioural therapy and deep brain stimulation).
Export Options
About this article
Cite this article as:
Bourin Michel and Thibaut Florence, A Critical Approach of the Current Treatment of Anxiety Disorders, Current Psychopharmacology 2013; 2 (2) . https://dx.doi.org/10.2174/2211556011302020002
DOI https://dx.doi.org/10.2174/2211556011302020002 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drugs that Activate Specific Nitric Oxide Sensitive Guanylyl Cyclase Isoforms Independent of Nitric Oxide Release
Current Medicinal Chemistry Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry The G Protein β3 Subunit Gene (GNB3) 825T Allele - a Thrifty Genotype
Current Genomics β-Secretase as a Therapeutic Target for Inhibitor Drugs
Current Medicinal Chemistry The Human Pseudoautosomal Region (PAR): Origin, Function and Future
Current Genomics Association Between Total Bilirubin Levels and Cardio-Metabolic Risk Factors Related to Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets Bitter Gourd (Momordica charantia) is a Cornucopia of Health: A Review of its Credited Antidiabetic, Anti-HIV, and Antitumor Properties
Current Molecular Medicine Incretins Yesterday, Pleiotropic Gastrointestinal Hormones Today:Glucagon-Like Peptide-1 (GLP-1) and Glucose-ependent Insulinotropic Polypeptide (GIP)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Oncologists Current Opinion on the Treatment of Colon Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms
Current Neuropharmacology Advanced Glycation: A Novel Outlook on Atherosclerosis
Current Pharmaceutical Design Safer Vectors for Gene Therapy of Primary Immunodeficiencies
Current Gene Therapy Effective Delivery of Male Contraceptives Behind the Blood-Testis Barrier (BTB) – Lesson from Adjudin
Current Medicinal Chemistry Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Current Pharmaceutical Design Mouse Models of Autoimmune Uveitis
Current Pharmaceutical Design Neuroinflamm-Aging and Neurodegenerative Diseases: An Overview
CNS & Neurological Disorders - Drug Targets Glucocorticoids and Vascular Reactivity
Current Vascular Pharmacology Innate Immune Inflammatory Response in the Acutely Ischemic Myocardium
Medicinal Chemistry Bioinformatic Analysis of HIV-1 Entry and Pathogenesis
Current HIV Research A Role for Milk Proteins and their Peptides in Cancer Prevention
Current Pharmaceutical Design